Overview
1. Executive Summary (Confidence: High)
Clee Medical SA is a Geneva-based medical technology company established in October 2024 as a high-stakes spin-off from the Wyss Center for Bio and Neuroengineering. The organization is dedicated to bridging the "intraoperative imaging gap" in neurosurgery, where surgeons currently rely on static, pre-operative scans that become inaccurate once the procedure begins. By integrating ultra-high-resolution Optical Coherence Tomography (OCT) with AI-guided navigation, Clee Medical provides real-time "vision" at the tip of surgical instruments. The company recently closed a successful Seed financing round led by High-Tech Gründerfonds (HTGF) to transition from preclinical research to human clinical validation. With a founding team experienced in developing market-standard neurosurgical platforms like the StealthStation, Clee Medical is positioned to become a category-defining player in the neurotechnology and longevity ecosystems.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.